| Heading: |
Puberty Suppressing Hormones |
| Question ID: |
1784006 |
| UIN: |
37793 |
| House: |
Commons |
| Date tabled: |
2025-03-12 |
| Asking Member ID: |
5110 |
| Asking Member display name: |
Euan Stainbank
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Euan Stainbank
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, when details of the trial on GnRH analogue puberty blockers will be submitted to the research ethics committee. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-25 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The PATHWAYS study proposal, including the clinical trial of puberty-suppressing hormones, is going through all the usual review and approval stages. These include independent academic peer review and National Institute for Health and Care Research fundin... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |